OSE Immunotherapeutics SA

Organization

Nantes CEDEX, FR

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method for manufacturing a stable emulsion for peptide delivery
- Patent number 11,981,713
- Issue date May 14, 2024
- OSE IMMUNOTHERAPEUTICS
- Jean-Pascal Conduzorgues
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and polypeptides directed against CD127
- Patent number 11,926,671
- Issue date Mar 12, 2024
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of anti-human SIRPa v1 antibodies and method for producing anti...
- Patent number 11,884,723
- Issue date Jan 30, 2024
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified bifunctional anti-human signal regulatory protein alpha (S...
- Patent number 11,713,356
- Issue date Aug 1, 2023
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer
- Patent number 11,696,936
- Issue date Jul 11, 2023
- OSE IMMUNOTHERAPEUTICS
- Dominique Costantini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating a pathological condition involving the activati...
- Patent number 11,440,964
- Issue date Sep 13, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for promoting t cells response by administering an antagoni...
- Patent number 11,365,257
- Issue date Jun 21, 2022
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Elise Chiffoleau
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Humanized anti-human-PD-1 antibody and its use in cancer treatment
- Patent number 11,352,430
- Issue date Jun 7, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for manufacturing a stable emulsion for peptide delivery
- Patent number 11,325,959
- Issue date May 10, 2022
- OSE IMMUNOTHERAPEUTICS
- Jean-Pascal Conduzorgues
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SIRPa antibodies and their therapeutic applications
- Patent number 11,279,766
- Issue date Mar 22, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Non-antagonistic antibodies directed against the alpha chain of the...
- Patent number 11,230,602
- Issue date Jan 25, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for inducing early T memory response with short peptides ant...
- Patent number 11,191,820
- Issue date Dec 7, 2021
- OSE IMMUNOTHERAPEUTICS
- Dominique Costantini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies and polypeptides directed against CD127
- Patent number 11,098,128
- Issue date Aug 24, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant monovalent antibodies
- Patent number 10,689,444
- Issue date Jun 23, 2020
- OSE IMMUNOTHERAPEUTICS
- Bernard Vanhove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic multi-peptides T specific immune therapy for treatment...
- Patent number 10,434,157
- Issue date Oct 8, 2019
- OSE IMMUNOTHERAPEUTICS
- Dominique Costantini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against CD127
- Patent number 10,428,152
- Issue date Oct 1, 2019
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 humanized antibodies
- Patent number 10,364,287
- Issue date Jul 30, 2019
- Institut National de la Sante et de la Recherche Medicale
- Caroline Mary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant monovalent antibodies
- Patent number 9,587,023
- Issue date Mar 7, 2017
- OSE IMMUNOTHERAPEUTICS
- Bernard Vanhove
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 humanized antibodies
- Patent number 9,562,098
- Issue date Feb 7, 2017
- OSE IMMUNOTHERAPEUTICS
- Caroline Mary
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against the alpha chain of IL7 receptor—their u...
- Patent number 9,447,182
- Issue date Sep 20, 2016
- OSE IMMUNOTHERAPEUTICS
- Sophie Brouard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Anti-Chemokin Like Receptor 1 Humanized Antibodies and Their Therap...
- Publication number 20240084019
- Publication date Mar 14, 2024
- OSE IMMUNOTHERAPEUTICS
- Vanessa Gauttier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL ANTI-PD1/IL-7 MOLECULES
- Publication number 20240067727
- Publication date Feb 29, 2024
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies Directed Against CD127
- Publication number 20230340133
- Publication date Oct 26, 2023
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- G01 - MEASURING TESTING
Information Patent Application
ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF
- Publication number 20230331852
- Publication date Oct 19, 2023
- OSE IMMUNOTHERAPEUTICS
- Elise CHIFFOLEAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL MOLECULES COMPRISING AN IL-7 VARIANT
- Publication number 20230303648
- Publication date Sep 28, 2023
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SIRPg Compounds
- Publication number 20230242640
- Publication date Aug 3, 2023
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for Treating CD127-Positive Cancers by Administering an Anti...
- Publication number 20230227565
- Publication date Jul 20, 2023
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SIRP-ALPHA ANTIBODIES
- Publication number 20230203188
- Publication date Jun 29, 2023
- Boehringer lngelheim International GmbH
- Jark BOETTCHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINE AGAINST SARS-COV VIRUS
- Publication number 20230181721
- Publication date Jun 15, 2023
- OSE IMMUNOTHERAPEUTICS
- DOMINIQUE COSTANTINI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING CD127 AND USE THEREOF
- Publication number 20230087125
- Publication date Mar 23, 2023
- Memorial Sloan-Kettering Cancer Center
- Prasad S. Adusumilli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE
- Publication number 20230071889
- Publication date Mar 9, 2023
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SIRP-ALPHA ANTIBODIES
- Publication number 20230012273
- Publication date Jan 12, 2023
- Boehringer Ingelheim International GmbH
- Jark BOETTCHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-CD28 Humanized Antibodies Formulated for Administration to Humans
- Publication number 20220411510
- Publication date Dec 29, 2022
- OSE IMMUNOTHERAPEUTICS
- Bernard Vanhove
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for Treating CD127-Positive Cancers by Administering an Anti...
- Publication number 20220389104
- Publication date Dec 8, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY
- Publication number 20220332826
- Publication date Oct 20, 2022
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
- Publication number 20220332834
- Publication date Oct 20, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR MODIFYING MACROPHAGE POLARIZATION INTO...
- Publication number 20220298259
- Publication date Sep 22, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method and Compositions for Inducing Differentiation of Myeloid Der...
- Publication number 20220281993
- Publication date Sep 8, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas Poirier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR PROMOTING T CELLS RESPONSE
- Publication number 20220281983
- Publication date Sep 8, 2022
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Elise CHIFFOLEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
- Publication number 20220281991
- Publication date Sep 8, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY
- Publication number 20220259277
- Publication date Aug 18, 2022
- OSE IMMUNOTHERAPEUTICS
- JEAN-PASCAL CONDUZORGUES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USES OF ANTI-SIRPg ANTIBODIES
- Publication number 20220242951
- Publication date Aug 4, 2022
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL ANTI-PD-1/SIRPA MOLECULE
- Publication number 20220056135
- Publication date Feb 24, 2022
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL MOLECULE DIRECTED AGAINST HUMAN PD-1
- Publication number 20220025050
- Publication date Jan 27, 2022
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127
- Publication number 20210395376
- Publication date Dec 23, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY
- Publication number 20210355225
- Publication date Nov 18, 2021
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED ANTI-SIRPA ANTIBODIES AND USES THEREOF
- Publication number 20210179728
- Publication date Jun 17, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPL...
- Publication number 20210147558
- Publication date May 20, 2021
- OSE IMMUNOTHERAPEUTICS
- NICOLAS POIRIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTI-HUMAN SIRPA V1 ANTIBODIES AND METHOD FOR PRODUCING ANTI...
- Publication number 20210040206
- Publication date Feb 11, 2021
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVED TREATMENT OF CANCER
- Publication number 20200384067
- Publication date Dec 10, 2020
- OSE IMMUNOTHERAPEUTICS
- DOMINIQUE COSTANTINI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98098906 - OSE-CYTOMASK
- Serial number 98098906
- Filing date Jul 24, 2023
- OSE Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98098791 - OSE-CYTOMASK
- Serial number 98098791
- Filing date Jul 24, 2023
- OSE Immunotherapeutics
- 44 - Medical services
Information Trademark
98098883 - OSE-CYTOMASK
- Serial number 98098883
- Filing date Jul 24, 2023
- OSE Immunotherapeutics
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97810640 - ARTEMIA
- Serial number 97810640
- Filing date Feb 24, 2023
- OSE Immunotherapeutics
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97263022 - MEMOPI
- Serial number 97263022
- Registration number 7090119
- Filing date Feb 11, 2022
- OSE Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97092394 - TEDOPI
- Serial number 97092394
- Filing date Oct 26, 2021
- OSE Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88136288 - B-COOL
- Serial number 88136288
- Registration number 6383178
- Filing date Sep 28, 2018
- OSE Immunotherapeutics
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88103626 - BICKI
- Serial number 88103626
- Registration number 5855074
- Filing date Sep 4, 2018
- OSE Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88103604 - B-TIC
- Serial number 88103604
- Registration number 6082824
- Filing date Sep 4, 2018
- OSE Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88103678 - BICKAN
- Serial number 88103678
- Registration number 6082825
- Filing date Sep 4, 2018
- OSE Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87092387 - ATALANTE
- Serial number 87092387
- Registration number 5231070
- Filing date Jul 4, 2016
- OSE Immunotherapeutics
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86942598 - OSE IMMUNOTHERAPEUTICS
- Serial number 86942598
- Registration number 5320086
- Filing date Mar 16, 2016
- OSE Immunotherapeutics
- 5 - Pharmaceutical and veterinary preparations

OSE Immunotherapeutics SA

Organization

Patents Grantslast 30 patents

Method for manufacturing a stable emulsion for peptide delivery

Antibodies and polypeptides directed against CD127

Use of anti-human SIRPa v1 antibodies and method for producing anti...

Modified bifunctional anti-human signal regulatory protein alpha (S...

Treatment of cancer

Method for treating a pathological condition involving the activati...

Methods for promoting t cells response by administering an antagoni...

Humanized anti-human-PD-1 antibody and its use in cancer treatment

Method for manufacturing a stable emulsion for peptide delivery

Anti-SIRPa antibodies and their therapeutic applications

Non-antagonistic antibodies directed against the alpha chain of the...

Method for inducing early T memory response with short peptides ant...

Antibodies and polypeptides directed against CD127

Recombinant monovalent antibodies

Therapeutic multi-peptides T specific immune therapy for treatment...

Antibodies directed against CD127

Anti-CD28 humanized antibodies

Recombinant monovalent antibodies

Anti-CD28 humanized antibodies

Antibodies directed against the alpha chain of IL7 receptor—their u...

Patents Applicationslast 30 patents

Anti-Chemokin Like Receptor 1 Humanized Antibodies and Their Therap...

BIFUNCTIONAL ANTI-PD1/IL-7 MOLECULES

Antibodies Directed Against CD127

ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF

BIFUNCTIONAL MOLECULES COMPRISING AN IL-7 VARIANT

ANTI-SIRPg Compounds

Method for Treating CD127-Positive Cancers by Administering an Anti...

ANTI-SIRP-ALPHA ANTIBODIES

VACCINE AGAINST SARS-COV VIRUS

CHIMERIC ANTIGEN RECEPTORS TARGETING CD127 AND USE THEREOF

BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE

ANTI-SIRP-ALPHA ANTIBODIES

Anti-CD28 Humanized Antibodies Formulated for Administration to Humans

Method for Treating CD127-Positive Cancers by Administering an Anti...

HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

METHODS AND COMPOSITIONS FOR MODIFYING MACROPHAGE POLARIZATION INTO...

Method and Compositions for Inducing Differentiation of Myeloid Der...

METHODS FOR PROMOTING T CELLS RESPONSE

ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

METHOD FOR MANUFACTURING A STABLE EMULSION FOR PEPTIDE DELIVERY

USES OF ANTI-SIRPg ANTIBODIES

BIFUNCTIONAL ANTI-PD-1/SIRPA MOLECULE

BIFUNCTIONAL MOLECULE DIRECTED AGAINST HUMAN PD-1

ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127

HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY

MODIFIED ANTI-SIRPA ANTIBODIES AND USES THEREOF

ANTI-CHEMOKIN LIKE RECEPTOR 1 ANTIBODIES AND THEIR THERAPEUTIC APPL...

USE OF ANTI-HUMAN SIRPA V1 ANTIBODIES AND METHOD FOR PRODUCING ANTI...

IMPROVED TREATMENT OF CANCER

Trademarklast 30 trademarks

98098906 - OSE-CYTOMASK

98098791 - OSE-CYTOMASK

98098883 - OSE-CYTOMASK

97810640 - ARTEMIA

97263022 - MEMOPI

97092394 - TEDOPI

88136288 - B-COOL

88103626 - BICKI

88103604 - B-TIC

88103678 - BICKAN

87092387 - ATALANTE

86942598 - OSE IMMUNOTHERAPEUTICS